Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 13/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.77 |
| ▸ | RAB9A | P51151 | 1/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | STAT6 | P42226 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrobenzylmercaptopurine Ribonucleoside SCHEMBL290702 | 1.00 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| Nitrobenzylmercaptopurine Ribonucleoside SCHEMBL29374837 | 1.00 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| Nitrobenzylmercaptopurine Ribonucleoside SCHEMBL7617534 | 1.00 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| SCHEMBL1763081 | 0.87 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| SCHEMBL20579724 | 0.87 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| SCHEMBL1322160 | 0.87 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| SCHEMBL29784689 | 0.87 | SLC29A1 (1.00) | SLC29A1CYP3A4TP53HIF1AABCC4 | |
| 6-Benzylthioinosine SCHEMBL3676029 | 0.86 | SLC29A1 (1.00) | SLC29A1STAT6 | |
| 6-Benzylthioinosine SCHEMBL7617372 | 0.86 | SLC29A1 (1.00) | SLC29A1STAT6 | |
| 6-Benzylthioinosine SCHEMBL7617380 | 0.86 | SLC29A1 (1.00) | SLC29A1STAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2702 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748207-A1 | SYSTEM AND METHOD FOR OPERATING A SET OF QUBITS AT A CRYOGENIC OPERATING TEMPERATURE | Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek TNO (NL) | 2026-05-27 | — | — | EP | claimed |
| CN-122091331-A | High-performance low-loss NbTi superconducting wire and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122050951-A | NbTi superconducting wire with high yield strength and preparation method thereof | 西安聚能超导线材科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122050954-A | Preparation method of niobium three-tin superconducting wire based on laser powder bed melting | 西安聚能超导线材科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260123292-A1 | Nonvolatile Memory Devices Based on Hybrid Magnetic-Superconductor Soliton States | US NAVY (US) | 2026-04-30 | — | — | US | claimed |
| EP-4722748-A1 | SUPERCONDUCTING SENSOR DEVICE AND CANTILEVER STRUCTURE FOR A SCANNING PROBE COMPRISING SUCH SUPERCONDUCTING SENSOR DEVICE | Quantamap B.V. (NL) | 2026-04-08 | — | — | EP | claimed |
| US-12584977-B2 | Magnetic field detector | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2026-03-24 | — | — | US | claimed |
| US-20260082823-A1 | SUPERCONDUCTIVE PASSIVE ELEMENT, MANUFACTURING METHOD FOR SUPERCONDUCTIVE PASSIVE ELEMENT, AND DEVICE INCLUDING SAID PASSIVE ELEMENT | RIKEN (JP) | 2026-03-19 | — | — | US | claimed |
| US-20260076101-A1 | AREA-SELECTIVE JOSEPHSON JUNCTION TUNNEL BARRIER FORMATION AND QUBIT CAP INTEGRATION | TOKYO ELECTRON LIMITED (JP) | 2026-03-12 | — | — | US | claimed |
| US-12575335-B2 | Superconducting microwave filters and filter elements for quantum devices | TECHNISCHE UNIVERSITEIT DELFT (NL) | 2026-03-10 | — | — | US | claimed |
| EP-1328261-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | Minerva Biotechnologies Corporation (US) | 2003-07-23 | — | — | EP | claimed |
| WO-2003057222-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A MULTIFUNCTIONAL PHOSPHODIESTERASE INHIBITOR AND AN ADENOSINE UPTAKE INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-17 | — | — | WO | claimed |
| US-20030060487-A1 | Treatment of neurodegenerative disease | MINERVA BIOTECHNOLOGIES CORPORATION | 2003-03-27 | — | — | US | claimed |
| EP-0755255-A4 | TREATMENT OF TOXOPLASMOSIS | RES CORP TECHNOLOGIES INC (US) | 2002-07-24 | — | — | EP | claimed |
| WO-2001078709-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | MINERVA BIOTECHNOLOGIES CORPORATION (US) | 2001-10-25 | — | — | WO | claimed |
| US-5780450-A | ADMINISTERING TOPICALLY, PARENTERALLY, ORALLY | ALCON LABORATORIES, INC. (US) | 1998-07-14 | — | — | US | claimed |
| WO-1997018815-A2 | THE USE OF ADENOSINE UPTAKE INHIBITORS FOR TREATING RETINAL OR OPTIC NERVE HEAD DAMAGE | ALCON LABORATORIES, INC. (US) | 1997-05-29 | — | — | WO | claimed |
| EP-0755255-A1 | TREATMENT OF TOXOPLASMOSIS | UNIVERSITY OF ALABAMA, BIRMINGHAM RESEARCH FOUNDATION (US) | 1997-01-29 | — | — | EP | claimed |
| WO-1996018398-A1 | TREATMENT OF TOXOPLASMOSIS | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM RESEARCH FOUNDATION (US) | 1996-06-20 | — | — | WO | claimed |
| EP-0235931-A1 | Antiviral combination | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-09-09 | — | — | EP | claimed |